NIH-sponsored clinical trials begin for antiviral drug AL721.
Bennett
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005989:Glycerides / Q000627:therapeutic use*; D006801:Humans; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D010714:Phosphatidylethanolamines / Q000627:therapeutic use*
D000998:Antiviral Agents; D004338:Drug Combinations; D005989:Glycerides; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; C046637:neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination